Contribution of Migraine to Cardiovascular Disease Risk Prediction
- PMID: 37286254
- DOI: 10.1016/j.jacc.2023.03.429
Contribution of Migraine to Cardiovascular Disease Risk Prediction
Abstract
Background: Migraine with aura (MA) is associated with cardiovascular disease (CVD) independently from traditional vascular risk factors. However, the importance of MA on CVD occurrence relative to existing cardiovascular prediction tools remains unclear.
Objectives: In this study, we sought to determine if adding MA status to 2 CVD risk prediction models improves risk prediction.
Methods: Participants enrolled in the Women's Health Study self-reported MA status and were followed for incident CVD events. We included MA status as a covariable in the Reynolds Risk Score and the American Heart Association (AHA)/American College of Cardiology (ACC) pooled cohort equation and assessed discrimination (Harrell c-index), continuous and categorical net reclassification improvement (NRI), and integrated discrimination improvement (IDI).
Results: MA status was significantly associated with CVD after including covariables in the Reynolds Risk Score (HR: 2.09; 95% CI: 1.54-2.84) and the AHA/ACC score (HR: 2.10; 95% CI: 1.55-2.85). Adding information on MA status improved discrimination of the Reynolds Risk Score model (from 0.792 to 0.797; P = 0.02) and the AHA/ACC score model (from 0.793 to 0.798; P = 0.01). We observed a small but statistically significant improvement in the IDI and continuous NRI after adding MA status to both models. We did not, however, observe significant improvements in the categorical NRI.
Conclusions: Adding information on MA status to commonly used CVD risk prediction algorithms enhanced model fit but did not substantially improve risk stratification among women. Despite the strong association of migraine with CVD risk, the relatively low prevalence of MA compared with other CV risk factors limits its usefulness in improving risk classification at the population level.
Keywords: cardiovascular disease; migraine; risk prediction.
Copyright © 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures The Women’s Health Study is funded by grants from the National Cancer Institute (CA047988 and UM1 CA182913) and the National Heart, Lung, and Blood Institute (HL043851, HL080467, and HL099355). Dr Rist was supported by a Career Development Award from the National Heart, Lung, and Blood Institute (K01 HL128791). This project was supported by a grant from the American Headache Society. Dr Rist received support from the American Headache Society for this work. Dr Kurth has received research grants from the Gemeinsamer Bundesausschuss (Federal Joint Committee, Germany) and the Bundesministerium für Gesundheit (Federal Ministry of Health, Germany); and has received personal compensation from Eli Lilly & Company, Teva Pharmaceuticals, TotalEnergies, BMJ, and Frontiers. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment in
-
Are We Sure We Know the Risk Factors for Cardiovascular Disease?J Am Coll Cardiol. 2023 Jun 13;81(23):2255-2257. doi: 10.1016/j.jacc.2023.04.012. J Am Coll Cardiol. 2023. PMID: 37286255 No abstract available.
Similar articles
-
Cardiovascular risk prediction: Can Systematic Coronary Risk Evaluation (SCORE) be improved by adding simple risk markers? Results from the Copenhagen City Heart Study.Eur J Prev Cardiol. 2016 Sep;23(14):1546-56. doi: 10.1177/2047487316638201. Epub 2016 Mar 14. Eur J Prev Cardiol. 2016. PMID: 26976846
-
Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic Women's Health Initiative.Circulation. 2012 Apr 10;125(14):1748-56, S1-11. doi: 10.1161/CIRCULATIONAHA.111.075929. Epub 2012 Mar 7. Circulation. 2012. PMID: 22399535 Free PMC article.
-
Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.Rheumatology (Oxford). 2017 Jul 1;56(7):1102-1110. doi: 10.1093/rheumatology/kex038. Rheumatology (Oxford). 2017. PMID: 28339992 Free PMC article.
-
Newest aspects on the association between migraine and cardiovascular disease: the role of modifying factors.Curr Pain Headache Rep. 2009 Jun;13(3):231-6. doi: 10.1007/s11916-009-0039-4. Curr Pain Headache Rep. 2009. PMID: 19457285 Review.
-
Migraine and cardiovascular disease: possible mechanisms of interaction.Neurology. 2009 May 26;72(21):1864-71. doi: 10.1212/WNL.0b013e3181a71220. Neurology. 2009. PMID: 19470970 Free PMC article. Review.
Cited by
-
Migraines and cardiovascular disease: mechanisms and methodological challenges.Nat Rev Cardiol. 2023 Dec;20(12):791-792. doi: 10.1038/s41569-023-00934-7. Nat Rev Cardiol. 2023. PMID: 37723319 No abstract available.
-
Causality between migraine and cardiovascular disease: a bidirectional Mendelian randomization study.J Headache Pain. 2024 Aug 13;25(1):130. doi: 10.1186/s10194-024-01836-w. J Headache Pain. 2024. PMID: 39135164 Free PMC article.
-
Cardiovascular Risk Scores and Migraine Status.JAMA Netw Open. 2024 Oct 1;7(10):e2440577. doi: 10.1001/jamanetworkopen.2024.40577. JAMA Netw Open. 2024. PMID: 39436645 Free PMC article.
-
Safety of Rimegepant in Adults with Migraine and Cardiovascular Risk Factors: Analysis of a Multicenter, Long-Term, Open-Label Study.Pain Ther. 2024 Oct;13(5):1203-1218. doi: 10.1007/s40122-024-00626-1. Epub 2024 Jul 10. Pain Ther. 2024. PMID: 38985436 Free PMC article.
-
Assessing the Causal Effect of Pulse Pressure on Migraine Risk: A Mendelian Randomization Study.J Pain Res. 2025 Jun 25;18:3159-3170. doi: 10.2147/JPR.S512795. eCollection 2025. J Pain Res. 2025. PMID: 40584772 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous